UNSPSC 41131513: Automated sedimentation rate device

In this classification, an automated sedimentation rate device is an instrument that measures automatically the erythrocyte sedimentation rate in whole blood. Because an increased sedimentation rate indicates tissue damage or inflammation, the erythrocyte sedimentation rate device is useful in monitoring treatment of a disease. US FDA regulates Automated sedimentation rate device under 21 CFR 864.5800 and under FDA product code GKB.

UNSPSC 41131513 Automated sedimentation rate device is a Commodity code covering laboratory diagnostic and analytical instruments that state and local public health agencies procure to support hematology and blood chemistry screening operations. Recent state and local opportunities under this code reflect purchases of complete automated analyzer systems and associated consumables—reagents, culture media, and sample-handling accessories—used in blood screening, hemoglobin analysis, and public health laboratory workflows. The issuing bodies include state departments of public health and state health and human services agencies responsible for maintaining diagnostic laboratory infrastructure across multiple facility locations.

California's Department of Public Health posted an RFB in August 2026 (due September 4, 2026) for public health laboratory supplies and media, including culture media, reagents, and consumables required for ongoing laboratory operations, with set-asides under California's Certified Business Enterprise program for small, minority-owned, women-owned, and disabled veteran-owned businesses. Texas Health and Human Services Commission and Department of State Health Services issued an IFB in May 2026 for a D-10 Hemoglobin Testing System with Rack Loader and accessories to replace aging equipment at the South Texas Lab in Harlingen, Texas, with a response deadline of May 18, 2026; the contract carried historical spending guidance of $45,050 to $80,000 and was contingent on Executive Commissioner approval and fund availability. Both solicitations reflect procurement activity centered in California and Texas, with emphasis on replacement of obsolete diagnostic equipment and supply replenishment cycles tied to annual public health laboratory operational budgets.